Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.7.0.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 2,148,753 $ 3,721,765
Accounts receivable, net 9,102,078 8,630,418
Unbilled revenue 2,347,055 2,269,645
Inventory, net 6,075,277 4,774,264
Due from related party 336,693 260,988
Prepaid and other current assets 601,437 401,876
Total current assets 20,611,293 20,058,956
Property, plant and equipment, net 548,111 517,143
Intangible assets, net 1,094,747 1,065,967
Goodwill 40,870 40,870
Other assets 2,128,300 2,058,425
TOTAL ASSETS 24,423,321 23,741,361
Current liabilities:    
Accounts payable 4,011,804 3,367,481
Accrued expenses 1,153,864 1,378,258
Deferred revenue 907,445 876,765
Total current liabilities 6,073,113 5,622,504
Long-term liabilities:    
Deferred revenue, net of current portion 489,959 459,275
Senior convertible promissory note, related party 3,148,712 3,148,509
Total liabilities 9,711,784 9,230,288
Commitments and contingencies
Tecogen Inc. shareholders’ equity:    
Common stock, $0.001 par value; 100,000,000 shares authorized; 20,043,052 and 19,981,912 issued and outstanding at March 31, 2017 and December 31, 2016, respectively 20,043 19,982
Additional paid-in capital 37,490,389 37,334,773
Accumulated deficit (22,798,895) (22,843,682)
Total stockholders’ equity 14,711,537 14,511,073
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 24,423,321 $ 23,741,361